Search - tctmd.com

Displaying 41 - 60 of 697

Sort: Relevancy | Date

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery

Michael O'Riordan

July 11, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Michael O'Riordan

December 18, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Presentation Cardiovascular Interventions 2023

Conversations in Cardiology Decisions Are Not Always Black and White

Presenter: Morton J. Kern

November 10, 2023

Presentation Cardiovascular Interventions 2023

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation Cardiovascular Interventions 2023

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

Presenter: Paul S. Teirstein

November 10, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Advertisement

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

DES Best for In-Stent Restenosis, but DCBs Also Viable

Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

DCB in STEMI Match DES Through 5 Years: REVELATION

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Coronary Artery Disease News of 2023

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Conversations in Cardiology Decisions Are Not Always Black and White

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content